JP2011520977A5 - - Google Patents

Download PDF

Info

Publication number
JP2011520977A5
JP2011520977A5 JP2011510691A JP2011510691A JP2011520977A5 JP 2011520977 A5 JP2011520977 A5 JP 2011520977A5 JP 2011510691 A JP2011510691 A JP 2011510691A JP 2011510691 A JP2011510691 A JP 2011510691A JP 2011520977 A5 JP2011520977 A5 JP 2011520977A5
Authority
JP
Japan
Prior art keywords
composition
pharmaceutically acceptable
solvate
compound
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011510691A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011520977A (ja
JP5757864B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/044743 external-priority patent/WO2009143295A1/en
Publication of JP2011520977A publication Critical patent/JP2011520977A/ja
Publication of JP2011520977A5 publication Critical patent/JP2011520977A5/ja
Application granted granted Critical
Publication of JP5757864B2 publication Critical patent/JP5757864B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011510691A 2008-05-20 2009-05-20 水溶性アセトアミノフェン類似体 Expired - Fee Related JP5757864B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5477408P 2008-05-20 2008-05-20
US61/054,774 2008-05-20
PCT/US2009/044743 WO2009143295A1 (en) 2008-05-20 2009-05-20 Water-soluble acetaminophen analogs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014049672A Division JP2014111658A (ja) 2008-05-20 2014-03-13 水溶性アセトアミノフェン類似体

Publications (3)

Publication Number Publication Date
JP2011520977A JP2011520977A (ja) 2011-07-21
JP2011520977A5 true JP2011520977A5 (https=) 2012-07-05
JP5757864B2 JP5757864B2 (ja) 2015-08-05

Family

ID=41340538

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2011510691A Expired - Fee Related JP5757864B2 (ja) 2008-05-20 2009-05-20 水溶性アセトアミノフェン類似体
JP2014049672A Withdrawn JP2014111658A (ja) 2008-05-20 2014-03-13 水溶性アセトアミノフェン類似体
JP2016016971A Expired - Fee Related JP6063072B2 (ja) 2008-05-20 2016-02-01 水溶性アセトアミノフェン類似体
JP2016242968A Withdrawn JP2017057217A (ja) 2008-05-20 2016-12-15 水溶性アセトアミノフェン類似体
JP2018098716A Withdrawn JP2018135392A (ja) 2008-05-20 2018-05-23 水溶性アセトアミノフェン類似体
JP2020074690A Withdrawn JP2020114876A (ja) 2008-05-20 2020-04-20 水溶性アセトアミノフェン類似体

Family Applications After (5)

Application Number Title Priority Date Filing Date
JP2014049672A Withdrawn JP2014111658A (ja) 2008-05-20 2014-03-13 水溶性アセトアミノフェン類似体
JP2016016971A Expired - Fee Related JP6063072B2 (ja) 2008-05-20 2016-02-01 水溶性アセトアミノフェン類似体
JP2016242968A Withdrawn JP2017057217A (ja) 2008-05-20 2016-12-15 水溶性アセトアミノフェン類似体
JP2018098716A Withdrawn JP2018135392A (ja) 2008-05-20 2018-05-23 水溶性アセトアミノフェン類似体
JP2020074690A Withdrawn JP2020114876A (ja) 2008-05-20 2020-04-20 水溶性アセトアミノフェン類似体

Country Status (12)

Country Link
US (4) US20110212926A1 (https=)
EP (1) EP2291348A4 (https=)
JP (6) JP5757864B2 (https=)
KR (1) KR101698028B1 (https=)
CN (2) CN102149672A (https=)
AU (1) AU2009249067A1 (https=)
BR (1) BRPI0912326A2 (https=)
CA (1) CA2724877C (https=)
IL (1) IL209382A0 (https=)
MX (1) MX2010012648A (https=)
RU (1) RU2010151952A (https=)
WO (1) WO2009143295A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2010151953A (ru) 2008-05-20 2012-06-27 Ньюроджесэкс, Инк. (Us) Карбонатные продукты и способы их применения
KR101717145B1 (ko) 2008-05-20 2017-03-16 노이로제스엑스, 인코포레이티드 간보호제 아세트아미노펜 공통 프로드러그
KR101698028B1 (ko) 2008-05-20 2017-01-26 노이로제스엑스, 인코포레이티드 수용성 아세트아미노펜 유사체
EP2177215A1 (en) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-crystals of tramadol and NSAIDs
WO2012137225A1 (en) * 2011-04-08 2012-10-11 Sphaera Pharma Pvt. Ltd Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
AU2012312136B2 (en) 2011-09-22 2017-06-29 Acorda Therapeutics, Inc. Acetaminophen conjugates, compositions and methods of use thereof
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP4578865A3 (en) 2014-08-12 2025-07-30 Monash University Lymph directing prodrugs
WO2016064873A1 (en) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
RU2743347C2 (ru) 2014-10-21 2021-02-17 Эббви Инк. Пролекарства карбидопа и l-dopa и их применение для лечения болезни паркинсона
EP3265097A4 (en) 2015-03-03 2018-11-07 Kindred Biosciences Inc. Compositions and methods for treatment and prevention of pyrexia in horses
CA2997106C (en) 2015-09-08 2024-06-04 Monash University Lymph directing prodrugs
EP3445346A1 (en) * 2016-04-20 2019-02-27 AbbVie Inc. Carbidopa and l-dopa prodrugs and methods of use
EP3675838A4 (en) 2017-08-29 2021-04-21 PureTech LYT, Inc. LIPID PRODRUGS DIRECTED TO THE LYMPHATIC SYSTEM
US11883497B2 (en) 2017-08-29 2024-01-30 Puretech Lyt, Inc. Lymphatic system-directing lipid prodrugs
EP3727362A4 (en) 2017-12-19 2021-10-06 PureTech LYT, Inc. MYCOPHENOLIC ACID LIPID PRODRUGS AND THEIR USES
US11304954B2 (en) 2017-12-19 2022-04-19 Puretech Lyt, Inc. Lipid prodrugs of mycophenolic acid and uses thereof
US11608345B1 (en) 2017-12-19 2023-03-21 Puretech Lyt, Inc. Lipid prodrugs of rapamycin and its analogs and uses thereof
EP3846852A4 (en) 2018-09-07 2022-06-15 R.P. Scherer Technologies, LLC Solid or semisolid lipid based dosage form stabilization through curing and addition of low hlb surfactant(s)
CN113015531A (zh) 2018-11-15 2021-06-22 艾伯维公司 用于皮下施用的药物调配物
US11389409B2 (en) * 2019-08-30 2022-07-19 Remedy Diagnostics LLC Transdermal device comprising acetaminophen prodrug
CN115348864A (zh) 2020-02-05 2022-11-15 纯技术Lyt股份有限公司 神经甾体的脂质前药

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2444043A1 (fr) * 1978-12-15 1980-07-11 Bottu Nouveau derive du paracetamol, son procede de preparation et son utilisation en therapeutique
DK406686D0 (da) * 1986-08-26 1986-08-26 Hans Bundgaard Carboxylsyrederivater
US5001115A (en) * 1989-05-17 1991-03-19 University Of Florida Prodrugs of biologically active hydroxyaromatic compounds
WO1991009831A1 (en) * 1989-12-26 1991-07-11 Nova Pharmaceutical Corporation Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use
US5627165A (en) * 1990-06-13 1997-05-06 Drug Innovation & Design, Inc. Phosphorous prodrugs and therapeutic delivery systems using same
US5272171A (en) * 1992-02-13 1993-12-21 Bristol-Myers Squibb Company Phosphonooxy and carbonate derivatives of taxol
US6750216B2 (en) * 1996-03-08 2004-06-15 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
IT1282736B1 (it) * 1996-05-21 1998-03-31 Angelini Ricerche Spa Uso di derivati del p-amminofenolo per preparare composizioni farmaceutiche utili nel trattamento di malattie neurodegenerative
DE69807464T2 (de) * 1997-05-15 2003-05-15 Drug Innovation & Design, Inc. Diester-derivate von acyclovir
KR20010033811A (ko) * 1997-12-31 2001-04-25 토마스 안 빅토리아 2차 및 3차 아민을 함유하는 약제의 물에 용해가능한프로드럭 및 그것의 제조방법
PT1056754E (pt) * 1998-01-29 2004-03-31 Bristol Myers Squibb Co Derivados fosfatados de 1,3,4-oxadiazolona de diarilo
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
US8231899B2 (en) * 1998-09-10 2012-07-31 Nycomed Danmark Aps Quick release pharmaceutical compositions of drug substances
ATE232382T1 (de) * 1998-09-10 2003-02-15 Nycomed Danmark As Pharmazeutische zusammensetzungen mit schneller freisetzung von wirkstoffen
US6461631B1 (en) * 1999-11-16 2002-10-08 Atrix Laboratories, Inc. Biodegradable polymer composition
US6362172B2 (en) 2000-01-20 2002-03-26 Bristol-Myers Squibb Company Water soluble prodrugs of azole compounds
MXPA02009552A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Derivados de imidazopiridina alquilada.
KR20040014544A (ko) * 2001-06-05 2004-02-14 컨트롤 딜리버리 시스템즈 인코포레이티드 서방 진통제 화합물
ATE373644T1 (de) * 2002-02-05 2007-10-15 Bristol Myers Squibb Co N-substituierte 3-hydroxy-4-pyridinone und diese enthaltende pharmazeutika
US20040058946A1 (en) * 2002-07-05 2004-03-25 Buchwald Stephen L. Abuse-resistant prodrugs of oxycodone and other pharmaceuticals
JP2006507322A (ja) * 2002-11-14 2006-03-02 シンタルガ・ビーブイ 多重自己脱離放出スペーサーとして構築されたプロドラッグ
US20040186081A1 (en) * 2003-03-03 2004-09-23 Guilford Pharmaceuticals Inc. Naaladase inhibitors for treating opioid tolerance
JP2006520392A (ja) * 2003-03-13 2006-09-07 コントロールド・ケミカルズ・インコーポレーテッド 薬物の乱用可能性を低下させ且つ作用持続時間を延長する化合物および方法
AU2003901813A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Pharmaceutical derivatives
US20050080260A1 (en) * 2003-04-22 2005-04-14 Mills Randell L. Preparation of prodrugs for selective drug delivery
US6992090B2 (en) * 2003-06-16 2006-01-31 Adolor Corporation Substituted piperidine compounds and methods of their use
US20050026879A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
WO2005077394A1 (en) * 2004-02-11 2005-08-25 Ramot At Tel-Aviv University Ltd Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
CN101023090B (zh) 2004-07-06 2013-03-27 雅培制药有限公司 Hiv蛋白酶抑制剂的前药
CN101678120A (zh) 2006-12-05 2010-03-24 纽罗吉斯克斯公司 前药及其制备和使用方法
KR101698028B1 (ko) 2008-05-20 2017-01-26 노이로제스엑스, 인코포레이티드 수용성 아세트아미노펜 유사체
RU2010151953A (ru) 2008-05-20 2012-06-27 Ньюроджесэкс, Инк. (Us) Карбонатные продукты и способы их применения
KR101717145B1 (ko) 2008-05-20 2017-03-16 노이로제스엑스, 인코포레이티드 간보호제 아세트아미노펜 공통 프로드러그
US8569466B2 (en) 2008-09-10 2013-10-29 Nnochiri Ekwuribe Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
CA2755069A1 (en) 2009-03-16 2010-09-23 Genmedica Therapeutics Sl Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders
AU2012312136B2 (en) 2011-09-22 2017-06-29 Acorda Therapeutics, Inc. Acetaminophen conjugates, compositions and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2011520977A5 (https=)
RU2010151952A (ru) Водорастворимые аналоги ацетаминофена
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
JP2011523645A5 (https=)
CY1121781T1 (el) Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης της ρασαγιλινης και χρησεις αυτων
CN1468111A (zh) 治疗急性、慢性疼痛和/或神经病性疼痛和偏头痛的药物组合物
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
RU2009118960A (ru) Комбинации ацетаминофена/ибуппрофена
RU2010151951A (ru) Общие пролекарства гепатопротектора и ацетаминофена
JP5952890B2 (ja) 膵臓癌を治療するための医薬製剤
JP2012533565A5 (https=)
JP2019511529A5 (https=)
JP7596323B2 (ja) ダクチノマイシン組成物並びに骨髄異形成症候群及び急性骨髄性白血病の治療方法
MX2013013014A (es) Metodo para el tratamiento de tumores solidos avanzados.
ES2649492T3 (es) (S)-pirlindol o sus sales farmacéuticamente aceptables para uso en medicina
AR078170A1 (es) Metodos para el tratamiento de tumores cerebrales
JP2026048781A (ja) インドール化合物を用いた疼痛又は間質性膀胱炎の治療方法
JP2014530204A5 (https=)
WO2018023098A1 (en) Radiolabeled ligands for targeted pet/spect imaging and methods of their use
JP2018530612A5 (https=)
RU2015117483A (ru) Комбинации
ES2649491T3 (es) (R)-pirlindol y sus sales farmacéuticamente aceptables para uso en medicina
RU2013148627A (ru) Производные тиено [2, 3-d] пиримидина и их применение для лечения аритмии
ES2423866B1 (es) Composición farmaceútica de ibuprofeno y tramadol para inyección
JP2009504668A5 (https=)